Accordingly, lower levels of ITGA2B and increased levels of the ER proteins P4HB, CALR and HSPA5 in patients with lung cancer and LA suggest some common affected pathways in their prothrombotic pathology. The gene discussed is P4HB; the disease is lung cancer.